Who are Postmenopausal, topical vaginal estrogen cream's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Estrogen vaginal cream, Premarin vaginal estrogen cream.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/postmenopausal-topical-vaginal-estrogen-cream.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Postmenopausal, topical vaginal estrogen cream — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Postmenopausal, topical vaginal estrogen cream (Postmenopausal, topical vaginal estrogen cream) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Estrogen replacement therapy (topical). Area: Gynecology / Women's Health.

marketed Estrogen replacement therapy (topical) Estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ) Gynecology / Women's Health Small molecule Live · refreshed every 30 min

Target snapshot

Postmenopausal, topical vaginal estrogen cream (Postmenopausal, topical vaginal estrogen cream) — The University of Texas Medical Branch, Galveston. Topical vaginal estrogen cream delivers estrogen directly to vaginal tissues to restore estrogen levels and alleviate symptoms of vaginal atrophy in postmenopausal women.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Postmenopausal, topical vaginal estrogen cream TARGET	Postmenopausal, topical vaginal estrogen cream	The University of Texas Medical Branch, Galveston	marketed	Estrogen replacement therapy (topical)	Estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ)
Estrogen vaginal cream	Estrogen vaginal cream	The University of Texas Health Science Center, Houston	marketed	Estrogen replacement therapy (topical)	Estrogen receptor alpha and beta
Premarin vaginal estrogen cream	Premarin vaginal estrogen cream	Medstar Health Research Institute	marketed	Estrogen replacement therapy (topical)	Estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Estrogen replacement therapy (topical) class)

Medstar Health Research Institute · 1 drug in this class
The University of Texas Health Science Center, Houston · 1 drug in this class
The University of Texas Medical Branch, Galveston · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Postmenopausal, topical vaginal estrogen cream — Competitive Intelligence Brief. https://druglandscape.com/ci/postmenopausal-topical-vaginal-estrogen-cream. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab